In vivo T‐cell depletion using alemtuzumab in family and unrelated donor transplantation for pediatric non‐malignant disease achieves engraftment with low incidence of graft vs. host disease

Publisher: John Wiley & Sons Inc

E-ISSN: 1399-3046|19|2|211-218

ISSN: 1397-3142

Source: PEDIATRIC TRANSPLANTATION, Vol.19, Iss.2, 2015-03, pp. : 211-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content